Abstract
Deregulation of apoptosis is responsible for diseases that involve defects in the death pathway, such as neoplasias, or in its inhibition, like degenerative processes. Among apoptosis- regulating molecules, a role is emerging for BAG3, a member of the BAG proteins family (BAG1L, BAG1, BAG2, BAG3, BAG4. BAG5 and BAG6) involved in cochaperoning of heat shock proteins. Through its BAG, WW and prolix-rich domains, BAG3 protein can interact with a variety of molecular partners, including Hsc70/Hsp70, phospholipase C-γ and others. It has been recently shown that, in human primary lymphoid and myeloblastic leukemias, thyroid carcinoma and other human tumors, BAG3 expression sustains cell survival and impairs cell response to therapy. This review discusses two patents concerning, respectively, BAG3 and other Hsc70/Hsp70 co-chaperones, namely HspBP-1 and HspBP-2.
Keywords: Apoptosis, cell survival, co-chaperone
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title: Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones
Volume: 3 Issue: 2
Author(s): Anna Basile, Morena d'Avenia, Alessandra Rosati, Michelina Festa, Antonia Falco, Maria C. Turco and Maria Pascale
Affiliation:
Keywords: Apoptosis, cell survival, co-chaperone
Abstract: Deregulation of apoptosis is responsible for diseases that involve defects in the death pathway, such as neoplasias, or in its inhibition, like degenerative processes. Among apoptosis- regulating molecules, a role is emerging for BAG3, a member of the BAG proteins family (BAG1L, BAG1, BAG2, BAG3, BAG4. BAG5 and BAG6) involved in cochaperoning of heat shock proteins. Through its BAG, WW and prolix-rich domains, BAG3 protein can interact with a variety of molecular partners, including Hsc70/Hsp70, phospholipase C-γ and others. It has been recently shown that, in human primary lymphoid and myeloblastic leukemias, thyroid carcinoma and other human tumors, BAG3 expression sustains cell survival and impairs cell response to therapy. This review discusses two patents concerning, respectively, BAG3 and other Hsc70/Hsp70 co-chaperones, namely HspBP-1 and HspBP-2.
Export Options
About this article
Cite this article as:
Basile Anna, d'Avenia Morena, Rosati Alessandra, Festa Michelina, Falco Antonia, Turco C. Maria and Pascale Maria, Novel Targets for Apoptosis Modulation: BAG3 Protein and Other Co- Chaperones, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2009; 3 (2) . https://dx.doi.org/10.2174/187221409788452318
DOI https://dx.doi.org/10.2174/187221409788452318 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
Current Neuropharmacology Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Gene Therapy in Cerebrovascular Diseases
Current Gene Therapy Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets Prevention of Intracerebral Haemorrhage
Current Drug Targets Subcutaneous Cavernous Haemangioma in a Patient with Klippel-Trenaunay Syndrome: A Case Report
Current Medical Imaging Interventional Radiology in Paediatrics
Current Pediatric Reviews Predictive Factor of Tumor Aggressiveness in Patients with Extrahepatic Cholangiocarcinoma Based on Diffusion-weighted MRI
Current Medical Imaging Medical Treatment of Uterine Arteriovenous Malformations: A Case Report
Current Women`s Health Reviews Fluorescein Fluorescence Use in the Management of Intracranial Neoplastic and Vascular Lesions: A Review and Report of a New Technique
Current Drug Discovery Technologies Cocaine Dependence and Stroke: Pathogenesis and Management
Current Neurovascular Research Neuropilin Signalling in Vascular Development and Pathology
Current Angiogenesis (Discontinued) Remodelling of the Ca2+ Toolkit in Tumor Endothelium as a Crucial Responsible for the Resistance to Anticancer Therapies
Current Signal Transduction Therapy Renal Ischemia: How Commonly Does it Cause Renal Failure?
Current Hypertension Reviews Neurological Disorders in Pregnancy
Current Women`s Health Reviews Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
Current Pharmaceutical Design A Variant in the Endoglin Gene is Associated with the Development of Sporadic Intracranial Aneurysms
Current Neurovascular Research Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews TGF-β Receptor Signaling Pathways in Angiogenesis; Emerging Targets for Anti-Angiogenesis Therapy
Current Pharmaceutical Biotechnology Acute Antithrombotic Treatment of Ischemic Stroke
Current Vascular Pharmacology